(Q48689670)

14 February 2018

title

Effect of silibinin on the growth and progression of primary lung tumors in mice. (English)

1 reference

14 February 2018

author

Rana P. Singh

1

1 reference

14 February 2018

author name string

Gagan Deep

2

1 reference

14 February 2018

Manesh Chittezhath

3

1 reference

14 February 2018

Manjinder Kaur

4

1 reference

14 February 2018

Lori D Dwyer-Nield

5

1 reference

14 February 2018

Alvin M Malkinson

6

1 reference

14 February 2018

Rajesh Agarwal

7

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 2006

1 reference

14 February 2018

Journal of the National Cancer Institute

published in

1 reference

14 February 2018

volume

98

1 reference

14 February 2018

page(s)

846-855

1 reference

14 February 2018

issue

12

1 reference

14 February 2018

Tobacco and the global lung cancer epidemic

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Tumor dormancy in vivo by prevention of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Chemoprevention of lung cancer--from biology to clinical reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silymarin: a review of its clinical properties in the management of hepatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Proliferating cell nuclear antigen (PCNA/cyclin) immunocytochemistry as a labeling index in mouse lung tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Cyclin D1 as a proliferative marker regulating retinoblastoma phosphorylation in mouse lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Cyclooxygenase as a target in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ231

1 reference

14 February 2018

PubMed ID

16788158

1 reference

14 February 2018